Crown Bioscience Strengthens Oncology Expertise with Acquisition of PRECOS Ltd
July 31st 2013Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has acquired the shares of Preclinical Oncology Services Limited (PRECOS), a leading pre-clinical research and development service provider with a specific focus on oncology.
The Science of Engagement in Clinical Trial Subject Enrollment
July 30th 2013Accessing and engaging patients is a very difficult task in today’s environment, as there is a bombardment of numerous media vehicles, including digital media, with varying intensities that penetrate patients’ senses, emotions, and thoughts.
Measuring Up: How Often is PRO Data Being Used in Health Technology Assessments?
July 30th 2013Physicians are increasingly advocating a patient-centered approach to practicing medicine, and both regulatory agencies and manufacturers also seem to agree that patient reported outcomes (PROs) are valuable.
The HIPAA/HITECH Omnibus Final Rule: Implications for Clinical Research Blog
July 26th 2013On January 23, 2013, the Department of Health and Humans Services (HHS) published the Omnibus Final Rule (Final Rule) which modifies the "HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the HITECH Act and the Genetic Information Nondiscrimination Act of 2008."
Clinical Research Advantage Acquires Late Phase Division of Comprehensive Clinical Development
July 24th 2013Clinical Research Advantage (CRA), a network of clinical trial sites, has further expanded its geographic and therapeutic reach by acquiring the late phase division of Comprehensive Clinical Development (CCD).
VirtualScopics Completes 6 week Analysis of Phase III Breast Cancer Study
July 22nd 2013VirtualScopics, Inc., a leading provider of quantitative imaging, today announced that they have completed analysis of a greater than 10,000 scan Phase III breast cancer study one week ahead of the six week contract period of the study utilizing a recently launched 3rd generation analysis platform.
Edging European Legislation Uphill From Vilnius
July 11th 2013The European Union's bid to update its clinical trials rules, "is particularly important for better competitiveness at global level, by encouraging research and innovation, maintaining a strong pharmaceutical industry and more clinical trials in Europe, and seeking better access to drugs for EU citizens."
Theorem Clinical Research, Emergo Group Form Strategic Relationship
July 9th 2013Theorem Clinical Research and Emergo Group have formed a strategic relationship to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community.